sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Discuss Q3 2024 Financials in Upcoming Investor Webcast
Jaguar Health, Inc. (NASDAQ:JAGX) has scheduled an investor webcast for Wednesday, November 13, 2024, at 8:30 a.m. Eastern. The company will review its third-quarter 2024 financials and provide corporate updates. The earnings report is set for release on the same day, filed on Form 10-Q for the quarter ending September 30, 2024.
Interested participants can register and access the webcast via the company's investor relations section. A replay will also be available for those unable to attend the live event.
Jaguar Health is a commercial-stage pharmaceuticals company, focusing on medicines derived from rainforest plants for gastrointestinal issues. Its subsidiary, Napo Pharmaceuticals, develops treatments for neglected gastrointestinal symptoms in complex disease states, including crofelemer for noninfectious diarrhea in adults with HIV/AIDS.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.